Syndrome News and Research

RSS

COVID-19 could trigger diabetes in healthy people

The coronavirus disease (COVID-19) causes severe illness in people with underlying health conditions, such as heart disease, hypertension, lung illness, and diabetes. Now, scientists warn that viral infection may trigger the development of diabetes in healthy people.

18 Jun 2020

SARS-CoV-2 found in river water, flags risk for humans, wildlife and livestock

Now, a new study by scientists in Ecuador and published on the preprint server medRxiv in June 2020 shows that the virus is present in river water too, which could imply a significant transmission risk in developing countries with inadequate sanitation facilities.

17 Jun 2020

Globally, 350 million could be at risk of severe COVID-19 and hospitalization

Now, a new study shows that one in five individuals is at risk of getting a severe case of COVID-19 due to the presence of underlying disease. The study appeared in the latest issue of The Lancet Global Health this week.

17 Jun 2020

Researchers use cellular nanosponges to soak up SARS-CoV-2

Scientists are working overtime to find an effective treatment for COVID-19, the illness caused by the new coronavirus, SARS-CoV-2.

17 Jun 2020

New test will help better manage patients with severe combined immunodeficiency

A new test developed at CHU Sainte-Justine in Montreal will enable better management of patients with severe combined immunodeficiency.

17 Jun 2020

Can a toilet flush spread coronavirus?

A new study by Chinese researchers at Yangzhou University shows how fluid dynamics can predict if flushing a toilet with the lid open could lead to the transmission of a virus. The study titled, “Can a toilet promote virus transmission? From a fluid dynamics perspective,” was published in the latest issue of the journal, The Journal of Acoustical Society of America (JASA).

17 Jun 2020

Integrin-binding peptide ATN-161: Potential COVID-19 treatment

Now, a new study by researchers at Tulane University and published on the preprint server bioRxiv* in June 2020 reports the potential role of an integrin inhibitor ATN-161 to prevent ACE2-S protein binding.

17 Jun 2020

ACE2 and pattern recognition receptor genes increase with age

A recent study by researchers in California and published on the preprint server bioRxiv* in June 2020 shows that advancing age is associated with increased expression of pattern recognition receptor (PRR) genes and ACE2 receptors, possibly accounting in part for the increased severity of the disease in older adults.

17 Jun 2020

Highly conserved RNA structures are essential for SARS-CoV-2 replication and pathogenesis

A recent study from the University of North Carolina at Chapel Hill revealed how selective pressure helps in preserving secondary RNA structures in coronavirus genomes, unveiling a pivotal role of these elements in viral replication and pathogenesis. The paper is currently available on the bioRxiv* preprint server.

17 Jun 2020

“Catch and kill” ventilation device destroys SARS-CoV-2, potential for airplanes - cruise ships

Researchers in Texas have developed an air conditioning system that can “catch and kill” severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) in an effort to help both essential works and the public combat coronavirus disease 2019 (COVID-19).

17 Jun 2020

Scientists examine SARS-CoV-2 cell entry in different species

Researchers in China have demonstrated the ability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to interact with the host cell receptors of multiple species of animals.

17 Jun 2020

Two clinical trials use low-dose X-rays to treat COVID-19 pneumonia

Previous studies have shown that low-dose, whole lung radiation in the form of X-rays can effectively treat severe pneumonia, with minimal side effects.

17 Jun 2020

NTU researchers develop a sustainable way to extract high-quality antimicrobial compounds

Scientists from Nanyang Technological University, Singapore have developed a sustainable and green way to extract high-quality antimicrobial compounds from seeds.

17 Jun 2020

C-OPN accelerates Parkinson’s disease research and treatment

Parkinson Canada invites people living with Parkinson’s disease to join the Canadian Open Parkinson Network to be part of the solution to improve lives for those living with Parkinson’s and ultimately to help discover a cure.

17 Jun 2020

SARS-CoV-2 mutated spike proteins show variations in cell entry

A new study by Japanese scientists published on the preprint server bioRxiv* in June 2020 shows that the D614g mutation in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein can enhance the infectivity of the virus while leaving it vulnerable to neutralization by antibodies.

17 Jun 2020

Novel ACE2-antibody fusion molecules show anti-SARS-CoV-2 activity

Now, in a new study published on the preprint server, bioRxiv researchers in the U.S. investigated a soluble version of ACE2 for SARS-CoV-2 viral neutralization activity.

17 Jun 2020

Norway pulls coronavirus contact tracing App due to privacy concerns

Amid the coronavirus pandemic, many countries have launched contact tracing apps to help contain the spread of the virus. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread across most of the world, now infecting more than 8.17 million people; hence, extensive contact tracing is a vital tool to prevent its vast spread.

17 Jun 2020

Beijing lockdown due to new SARS-CoV-2 cluster, New Zealand records first case in weeks

China had started to return to normalcy after successfully "flattening the curve," with the government slowly easing restrictions and opening up the economy. However, Beijing has reported new clusters of coronavirus disease (COVID-19) cases, prompting the implementation of lockdown measures.

17 Jun 2020

Scientists isolate powerful SARS-CoV-2 -neutralizing antibodies from COVID-19 patients

A new study has shown that potent antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could help protect against COVID-19 infection. Preliminary results in animal studies have so far proven successful. The study titled, "Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model," was published in the latest issue of the journal Science.

17 Jun 2020

Antibiotic X-206 effective against SARS-CoV-2 in vitro

The current study published on the preprint server bioRxiv aims to understand how these compounds affect SARS-CoV-2 in vitro. The researchers from Aarhus University in Denmark examined 11 natural PEIs, with a single synthetic analog, screening them for inhibitory activity against the CPE of SARS-CoV-2 infecting cultured cells with overexpression of TMPRSS2, a serine protease that is instrumental in cleaving the spike protein of the virus.

16 Jun 2020